China Universal Asset Management »

Cytokinetics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 20k 70.11
2023-12-31 $947k 11k 83.50
2023-09-30 $73k 2.5k 29.64
2023-06-30 $41k 1.3k 32.70
2023-03-31 $45k 1.3k 35.10
2022-12-31 $44k 961 45.79
2022-09-30 $1.4M 28k 48.45

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Susquehanna International
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics